Peptide Schedule

KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) Blend Calculator

Healing & RecoveryInjectionResearchVaries by component half-life

Calculate exact syringe units for the KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) pre-mixed blend. The dose shown is from the combined vial — no separate math needed.

2mg · Daily

100500
7.5 units
100 units (1mL)
Concentration
26,666.667
mcg/mL
Draw Volume
0.075
mL
Syringe Units
7.5
units
Doses / Vial
40
doses

Summary: Add 3mL BAC water to your 80mg vial. Draw to 7.5 units on a U-100 syringe for a 2mg dose. This vial will last 40 doses.

Cycle Planner

What's in This Blend

About This Blend

The KLOW Protocol is a pre-blended four-peptide stack that combines GHK-Cu, BPC-157, TB-500, and KPV into a single 80mg vial. Originally developed as a recovery and tissue repair blend, it's gained traction in the weight management space because of its ability to support body recomposition during aggressive fat loss phases. Each component targets a different biological pathway. GHK-Cu (50mg per vial) is a copper-binding tripeptide first isolated by Loren Pickart in 1973. It drives collagen and elastin synthesis, supports skin tightening during weight loss, and activates antioxidant gene expression. BPC-157 (10mg per vial) is a 15-amino-acid fragment derived from human gastric juice. Predrag Sikiric's research group in Zagreb has published over 100 preclinical studies showing it accelerates tendon, ligament, and gut mucosal healing — all of which matter during caloric restriction when tissue repair slows. TB-500 (10mg per vial) is a synthetic fragment of thymosin beta-4. Goldstein and Kleinman's early work demonstrated its role in cell migration, angiogenesis, and wound repair. It helps maintain muscle integrity during aggressive cutting phases. KPV (10mg per vial) is a C-terminal tripeptide from alpha-melanocyte stimulating hormone. Bhatt et al. (2008) showed it enters intestinal epithelial cells via the PepT1 transporter and suppresses NF-kB inflammatory signaling at nanomolar concentrations. This makes KPV especially useful for calming gut inflammation triggered by dietary changes or GLP-1 agonist side effects. The blend doesn't directly burn fat. Instead, it creates a protective internal environment — healing the gut lining, reducing systemic inflammation, preserving connective tissue, and supporting skin elasticity — that allows users to sustain more aggressive weight loss protocols with fewer side effects and less tissue breakdown.

Reduces systemic inflammation through NF-kB pathway suppression via KPV
Accelerates gut mucosal healing — especially useful during GLP-1 therapy
Supports skin elasticity and collagen production during rapid weight loss
Promotes tendon and ligament repair via BPC-157 and TB-500
Enhances wound healing and tissue remodeling through multiple pathways
Preserves muscle and connective tissue integrity during caloric restriction
Supports body recomposition when combined with exercise and diet protocols
View full blend guide →

Frequently Asked Questions